Skip to main content
REGENERON PHARMACEUTICALS, INC. logo

REGENERON PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · REGN ISIN · US75886F1075 LEI · 549300RCBFWIRX3HYQ56 US Manufacturing
Filings indexed 1,720 across all filing types
Latest filing 2020-11-05 Interim / Quarterly Rep…
Country US United States of America
Listing US REGN

About REGENERON PHARMACEUTICALS, INC.

https://www.regeneron.com/

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases. The company's research and development efforts are focused on a wide range of therapeutic areas, including ophthalmology, cancer, allergic and inflammatory diseases, cardiovascular and metabolic disorders, and rare diseases. Regeneron leverages its expertise in biologics and genetic medicines to translate scientific breakthroughs into transformative treatments for patients.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2020
2020-11-05 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 5, 2020, reporting the issuance of a press release announcing financial and operating results for the quarter ended September 30, 2020. The text states that the press release is furnished as an exhibit and incorporated by reference, indicating this document itself is a current report filing rather than the full earnings release. The document length is 3652 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing the full financial results. According to the rules, such filings that announce or furnish a press release of quarterly results but do not contain the full financial data themselves should be classified as Regulatory Filings (RNS), not as Earnings Release (ER) or Interim Report (IR).
2020-11-05 English
PRIMARY DOCUMENT
Director's Dealing
2020-11-03 English
PRIMARY DOCUMENT
Director's Dealing
2020-10-23 English
PRIMARY DOCUMENT
Director's Dealing
2020-10-06 English
PRIMARY DOCUMENT
Director's Dealing
2020-10-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.